/

Workspace

Research & Review

Writing & Publishing

Data & Analysis

Utilities

Account

User Settings

R

Rodney P. Rocconi

University of Mississippi Medical Center(US)

Claim or correct this author profile

Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.

252

Papers

4.2K

Citations

35

h-index

88

i10-index

Rodney P. Rocconi is an academic researcher from University of Mississippi Medical Center. The author has contributed to research in topics: Ovarian cancer diagnosis and treatment & Endometrial and Cervical Cancer Treatments & Uterine Myomas and Treatments. The author has an h-index of 35, co-authored 215 publications.

ORCID: 0000-0001-8642-5859

Research Topics

Ovarian cancer diagnosis and treatment Endometrial and Cervical Cancer Treatments Uterine Myomas and Treatments Cervical Cancer and HPV Research PARP inhibition in cancer therapy

Papers by this author

works

Racial health disparities in ovarian cancer: not just black and white

2017 · Journal of Ovarian Research · 64 citations

https://doi.org/10.1186/s13048-017-0355-y

Sanjeev K. Srivastava Aamir Ahmad Orlandric Miree Girijesh Kumar Patel

ENTPD1/CD39 as a predictive marker of treatment response to gemogenovatucel-T as maintenance therapy in newly diagnosed ovarian cancer

2022 · Communications Medicine · 13 citations

https://doi.org/10.1038/s43856-022-00163-y

Rodney P. Rocconi Laura Stanbery Min Tang Luciana Madeira da Silva

Corrigendum to “Long-term follow-up of Phase 2A trial results involving advanced ovarian cancer patients treated with Vigil® in frontline maintenance” [Gynecol. Oncol. Rep. 34 (2020) 100648]

2021 · Gynecologic Oncology Reports · 3 citations

https://doi.org/10.1016/j.gore.2021.100740

Jonathan Oh Minal Barve Neil Senzer Phylicia Aaron

Repair Assisted Damage Detection (RADD) as a predictive biomarker for immunotherapy response in ovarian cancer

2024 · Gynecologic Oncology · 1 citations

https://doi.org/10.1016/j.ygyno.2024.11.006

Manoj Sonavane Jenna Hedlich-Dwyer Valeria L. Dal Zotto Min Tang

Racial disparities in survival and molecular features among Black versus White patients with uterine serous carcinoma: An integrated study in real-world registries and legacy NRG Oncology/Gynecologic Oncology Group clinical trials

2024 · Gynecologic Oncology · 0 citations

https://doi.org/10.1016/j.ygyno.2024.07.179

Jordyn Tumas Chunqiao Tian Zachary A Kopelman Neil T. Phippen

Repair-assisted damage detection as a potential predictive biomarker for immunotherapy response in ovarian cancer

2024 · Gynecologic Oncology · 0 citations

https://doi.org/10.1016/j.ygyno.2024.07.033

Rodney P. Rocconi Jenna Hedlich Valeria Dal Zotto Manoj Sonavane

Research topics

topics

Ovarian cancer diagnosis and treatment

Endometrial and Cervical Cancer Treatments

Uterine Myomas and Treatments

Cervical Cancer and HPV Research

PARP inhibition in cancer therapy

Chat about Author

Papers

Chat

Click to start Chat